SARS-like WIV1-CoV poised for human emergence

Menachery, Vineet D., Yount, Boyd L., Sims, Amy C., Debbink, Kari, Agnihothram, Sudhakar S., Gralinski, Lisa E., Graham, Rachel L., Scobey, Trevor +10 more·2016·Proceedings of the National Academy of Sciences

Cited by (420)

Items 201–300 of 420

  1. Animal Models of COVID-19. I. Comparative Virology and Disease Pathogenesis
    Caroline J. Zeiss, Susan R Compton, Rebecca T. Veenhuis · 2021 · ILAR Journal
  2. Engineered immunogens to elicit antibodies against conserved coronavirus epitopes
    2023
  3. The continued epidemic threat of SARS-CoV-2 and implications for the future of global public health
    Timothy Patrick Sheahan, Matthew B. Frieman · 2020 · Current Opinion in Virology
  4. Broad host tropism of ACE2-using MERS-related coronaviruses and determinants restricting viral recognition
    Chengbao Ma, Chen Liu, Qing Xiong, Mengxue Gu, Lulu Shi, Chunli Wang, Junyu Si, Fei Tong, Peng Liu, Meiling Huang et al. · 2023 · Cell Discovery
  5. An Epidemiological Characteristic of the COVID-19 Among Children
    2020 · Letters in Applied NanoBioScience
  6. SARS-Like Coronavirus WIV1-CoV Does Not Replicate in Egyptian Fruit Bats (Rousettus aegyptiacus)
    Neeltje van Doremalen, Alexandra Schäfer, Vineet D. Menachery, Michael C. Letko, Trenton Bushmaker, Robert J. Fischer, Dania M. Figueroa, Patrick W. Hanley, Greg A. Saturday, Ralph Steven Baric et al. · 2018 · Viruses
  7. Phytotherapy for treatment of cytokine storm in COVID-19
    Leena Sapra, Asha Bhardwaj, Zaffar Azam, Deekhsha Madhry, Bhupendra Verma, Sumit Rathore, Rupesh Kumar Srivastava · 2021 · Frontiers in Bioscience-Landmark
  8. Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines
    Jie Zhou, Zezhong Liu, Guangxu Zhang, Wei Xu, Lixiao Xing, Lu Lu, Qian Wang, Shibo Jiang · 2022 · Journal of Medical Virology
  9. A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice
    Meiqin Liu, Haofeng Lin, Jing Li, Ying Chen, Yun Luo, Wei Zhang, Ben Hu, Fengjuan Tian, Yunjia Hu, Yujie Liu et al. · 2023 · Journal of Virology
  10. Multivalent S2 subunit vaccines provide broad protection against Clade 1 sarbecoviruses in female mice
    Peter Halfmann, Raj S. Patel, Kathryn Loeffler, Atsuhiro Yasuhara, Lee-Ann Van de Velde, Jie E Yang, Jordan C. Chervin, Chloe A. Troxell, Min Huang, Nai‐Ying Zheng et al. · 2025 · Nature Communications
  11. Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice
    Adam S. Cockrell, Sarah R. Leist, Madeline G. Douglas, Ralph Steven Baric · 2018 · Mammalian Genome
  12. Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
    Susanna K. P. Lau, Antonio C. P. Wong, Hayes K. H. Luk, Kenneth S. M. Li, Joshua Fung, Zirong He, Flora Ka-Kei Cheng, Tony Tat-Yin Chan, Stella Chu, Kam Leng Aw‐Yong et al. · 2020 · Emerging infectious diseases
  13. A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules
    Devendra Kumar, Gaurav Chauhan, Sourav Kalra, Bhupinder Kumar, Manjinder Singh Gill · 2020 · Bioorganic Chemistry
  14. Mouse models in COVID-19 research: analyzing the adaptive immune response
    S. Clever, A. Volz · 2022 · Medical Microbiology and Immmunology
  15. SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator Modulators
    José M. Honrubia, Francisco J. Gutierrez-Alvarez, Alejandro Sanz‐Bravo, Ezequiel González-Miranda, Diego Muñoz‐Santos, Carlos Castaño-Rodríguez, Li Wang, Marta Villarejo-Torres, Jorge Ripoll-Gómez, Ana Esteban et al. · 2023 · mBio
  16. Protein-based nano-vaccines against SARS-CoV-2: Current design strategies and advances of candidate vaccines
    Dongliang Wang, Youqing Yuan, Bin Liu, Neal D. Epstein, Yi Yang · 2023 · International Journal of Biological Macromolecules
  17. Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein
    Anna Z. Wec, Daniel Wrapp, Andrew S. Herbert, Daniel P. Maurer, Denise Haslwanter, Mrunal Sakharkar, Rohit K. Jangra, M. Eugenia Dieterle, Asparouh Lilov, Deli Huang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  18. Rapid selection of a human monoclonal antibody that potently neutralizes SARS-CoV-2 in two animal models
    Wei Li, Aleksandra K. Drelich, David R. Martinez, Lisa E. Gralinski, Chuan Chen, Zehua Sun, Alexandra Schäfer, Sarah R. Leist, Xianglei Liu, Doncho V. Zhelev et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Remdesivir Potently Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
    Andrea J. P. Pruijssers, Amelia S. George, Alexandra Schäfer, Sarah R. Leist, Lisa E. Gralinski, Kenneth H. Dinnon, Boyd L. Yount, Maria L. Agostini, Laura J. Stevens, James D. Chappell et al. · 2020 · SSRN Electronic Journal
  20. A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia
    Cecilia A. Sánchez, Hongying Li, Kendra L. Phelps, Carlos Zambrana‐Torrelio, Lin‐Fa Wang, Kevin J. Olival, Peter Daszak · 2021 · medRxiv
  21. Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates
    Yan-Feng Yao, Ze-Jun Wang, Ren-Di Jiang, Xue Hu, Huajun Zhang, Yi-Wu Zhou, Ge Gao, Ying Chen, Yun Peng, Mei-Qin Liu et al. · 2021 · Virologica Sinica
  22. Cell and Animal Models for SARS-CoV-2 Research
    Eloïne Bestion, P. Halfon, S. Mezouar, J. Mege · 2022 · Viruses
  23. A Multitrait Locus Regulates Sarbecovirus Pathogenesis
    Alexandra Schäfer, Sarah R. Leist, Lisa E. Gralinski, David R. Martinez, Emma S. Winkler, Kenichi Okuda, Padraig Hawkins, Kendra L. Gully, Rachel L. Graham, D. Trevor Scobey et al. · 2022 · mBio
  24. The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses
    David R. Martinez, Fernando R. Moreira, Nicholas Catanzaro, Meghan V. Diefenbacher, Mark R. Zweigart, Kendra L. Gully, Gabriela De la Cruz, Ariane J. Brown, Lily E. Adams, Boyd L. Yount et al. · 2024 · Science Translational Medicine
  25. Next-Generation High-Throughput Functional Annotation of Microbial Genomes
    Ralph Steven Baric, Sean Crosson, Blossom Damania, Samuel I. Miller, Eric J. Rubin · 2016 · mBio
  26. Crystal structure of the post-fusion core of theHuman coronavirus 229Espike protein at 1.86 Å resolution
    Lei Yan, Bing Meng, Jiangchao Xiang, Ian A. Wilson, Bei Yang · 2018 · Acta Crystallographica Section D Structural Biology
  27. A tool for rapid assessment of wildlife markets in the Asia-Pacific Region for risk of future zoonotic disease outbreaks
    Eric Wikramanayake, Dirk Udo Pfeiffer, Ioannis Magouras, Anne Conan, Stefan Ziegler, Timothy C. Bonebrake, David Mark Olson · 2021 · One Health
  28. Animal Models of Long Covid: A Hit-and-Run Disease
    A. Schäfer, S. Leist, John M. Powers, R. Baric · 2024 · Science Translational Medicine
  29. Past, present, and future of COVID-19: a review
    Camila Malta Romano, Alberto Chebabo, José Eduardo Levi · 2020 · Brazilian Journal of Medical and Biological Research
  30. In Search of Herbal Anti-SARS-Cov2 Compounds
    Tatiana V. Matveeva, Galina V. Khafizova, С. В. Сокорнова · 2020 · Frontiers in Plant Science
  31. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice
    Isabelle Dubuc, Julien Prunier, Émile Lacasse, Annie Gravel, Florian Puhm, Isabelle Allaeys, Anne‐Sophie Archambault, Leslie Gudimard, Rosaria Villano, Arnaud Droit et al. · 2022 · Frontiers in Immunology
  32. An updated review on pathogenic coronaviruses (CoVs) amid the emergence of SARS-CoV-2 variants: A look into the repercussions and possible solutions
    Ali Ahmed Rabaan, Maha Fahad Alenazy, Ahmad A. Alshehri, Mohammed Abdulrahman Alshahrani, Maha F. Al‐Subaie, Hayam Ali AlRasheed, Nawal Ahmed Mohamed Al Kaabi, Nanamika Thakur, Nabiha A. Bouafia, Mohammed Alissa et al. · 2023 · Journal of Infection and Public Health
  33. Experimental Animal Models of Coronavirus Infections: Strengths and Limitations
    Mark Anthony B. Casel, Rare Rollon, Young Ki Choi · 2021 · Immune Network
  34. Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody
    M. Alejandra Tortorici, Nadine Czudnochowski, Tyler N. Starr, Roberta Marzi, Alexandra C. Walls, Fabrizia Zatta, John E. Bowen, Stefano Jaconi, Julia di Iulio, Zhaoqian Wang et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  35. Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements
    John N. Snouwaert, Leigh A. Jania, Trang Thi Huyen Nguyen, David R. Martinez, Alexandra Schäfer, Nicholas Catanzaro, Kendra L. Gully, Ralph Steven Baric, Mark T. Heise, Martin T. Ferris et al. · 2023 · PLoS Pathogens
  36. A computationally designed ACE2 decoy has broad efficacy against SARS-CoV-2 omicron variants and related viruses in vitro and in vivo
    Brandon Havranek, Graeme Lindsey, Yusuke Higuchi, Yumi Itoh, Tatsuya Suzuki, Toru Okamoto, Atsushi Hoshino, Erik Procko, Shahidul M. Islam · 2023 · Communications Biology
  37. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
    Simona Dedoni, Valeria Avdoshina, Chiara Camoglio, Carlotta Siddi, Walter Fratta, María Scherma, Paola Fadda · 2022 · Molecules
  38. Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice
    David R. Martinez, Alexandra Schäfer, Tyler D. Gavitt, Michael L. Mallory, Esther Lee, Nicholas Catanzaro, Haiyan Chen, Kendra L. Gully, Trevor Scobey, Pooja Korategere et al. · 2023 · Cell Reports
  39. Structural determinants of spike infectivity in bat SARS-like coronaviruses RsSHC014 and WIV1
    Shuyuan Qiao, Xinquan Wang · 2024 · Journal of Virology
  40. A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice
    James Brett Case, Shilpa Sanapala, Carly A. Dillen, Victoria Rhodes, Christian M. Zmasek, Taras M. Chicz, Charlotte Switzer, Suzanne M. Scheaffer, Georgi Petrov Georgiev, Catherine Jacob-Dolan et al. · 2024 · Cell Host & Microbe
  41. Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses
    Bryan A. Johnson, Rachel L. Graham, Vineet D. Menachery · 2017 · Virology
  42. Novel transgenic mice with Cre-dependent co-expression of GFP and human ACE2: a safe tool for study of COVID-19 pathogenesis
    Alexandra V. Bruter, Diana S. Korshunova, Marina V. Kubekina, Сергиев Петр Владимирович, Anastasiia A. Kalinina, Leonid A. Ilchuk, Yulia Yu. Silaeva, Eugenii N. Korshunov, Vladislav O. Soldatov, Alexey V. Deykin · 2021 · Transgenic Research
  43. Metagenomics: Preventing Future Pandemics
    Abigail Sawyer, Tristan Free, Joseph Martin · 2021 · BioTechniques
  44. Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)
    Bahaa Abu-Raya, Giovanni Battista Migliori, Miguel O’Ryan, Kathryn M. Edwards, Antoní Torres, Jan‐Willem C. Alffenaar, Anne‐Grete Märtson, Rosella Centis, Lia D’Ambrosio, Katie L. Flanagan et al. · 2020 · Frontiers in Medicine
  45. Of mice and human-specific long noncoding RNAs
    Amr R. Ghanam, William Bart Bryant, Joseph M. Miano · 2022 · Mammalian Genome
  46. Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals
    Ethan J. Fritch, Angie L. Mordant, Thomas S.K. Gilbert, Carrow I. Wells, Xuan Yang, Natalie K. Barker, Emily A. Madden, Kenneth H. Dinnon, Yixuan Jacob Hou, Longping V. Tse et al. · 2023 · Journal of Proteome Research
  47. Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus
    Jacob A. Dillard, Sharon Taft-Benz, Audrey C. Knight, Elizabeth J. Anderson, Katia D. Pressey, Breantié Parotti, Sabian A. Martinez, Jennifer Diaz, Sanjay Sarkar, Emily A. Madden et al. · 2024 · Nature Communications
  48. Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
    Cara W. Chao, Kaitlin R. Sprouse, Marcos C. Miranda, Nicholas Catanzaro, Miranda L. Hubbard, Amin Addetia, Cameron Stewart, Jack T Brown, Annie M. Dosey, Adian Valdez et al. · 2024 · Cell Reports
  49. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
    Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Yu Erica Lee, Pauline R. Hoffman, Susan Ou, Leesa M. Kakutani, Jennifer R. Keeffe, Hung-Jen Wu, Mark R. Howarth, Anthony P. West et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  50. The Reassessed Potential of SARS-CoV-2 Attenuation for COVID-19 Vaccine Development—A Systematic Review
    Marcin Goławski, Piotr Lewandowski, Iwona Jabłońska, Marcin Delijewski · 2022 · Viruses
  51. Pandemic Vaccines: How Are We Going to Be Better Prepared Next Time?
    Florian Krammer · 2020 · Med
  52. Mucin 4 Protects Female Mice from Coronavirus Pathogenesis
    Jessica A. Plante, Kenneth S. Plante, Lisa E. Gralinski, Anne E. Beall, Martin T. Ferris, Daniel Bottomly, Richard R. Green, Shannon K. McWeeney, Mark T. Heise, Ralph Steven Baric et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Moving beyond metagenomics to find the next pandemic virus
    Vincent R. Racaniello · 2016 · Proceedings of the National Academy of Sciences
  54. Viral Diseases Transmissible by Kissing
    Jacobo Limeres Posse, Pedro Diz Dios, Crispian M. Scully · 2017 · Elsevier eBooks
  55. Pathogenesis and virulence of coronavirus disease: Comparative pathology of animal models for COVID-19
    Natalie M. Kirk, Yu-Ying Liang, H. Ly · 2024 · Virulence
  56. SARS-CoV-2-related bat viruses evade human intrinsic immunity but lack efficient transmission capacity
    Mario A. Peña-Hernández, M. M. Alfajaro, R. Filler, Miyu Moriyama, Emma L. Keeler, Zara E Ranglin, Yong Kong, T. Mao, Bridget L. Menasché, Madeleine C. Mankowski et al. · 2024 · Nature Microbiology
  57. Debunking Myths about COVID-19, Paranoiac Misconceptions, Recent Developments and its Current Stance
    Zumama Khalid, Muhammad Abrar Yousaf, Abeedha Tu-Allah Khan, Farah Rauf Shakoori, Muhammad Munir, Abdul Rauf Shakoori · 2020 · Pakistan Journal of Zoology
  58. Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant
    Angelina O. Kovalenko, Ekaterina M. Ryabchevskaya, Ekaterina A. Evtushenko, Tatiana I. Manukhova, Olga A. Kondakova, Ivanov Pa, Marina V. Arkhipenko, Vladimir А. Gushchin, Nikolai A. Nikitin, Olga V. Karpova · 2022 · Frontiers in Microbiology
  59. The furin cleavage site is required for pathogenesis, but not transmission, of SARS-CoV-2
    Angelica L. Morgan, Michelle N. Vu, Yiyang Zhou, Kumari G. Lokugamage, William M. Meyers, R. Elias Alvarado, Yani P. Ahearn, Leah K. Estes, Jessica A. Plante, Bryan A. Johnson et al. · 2025 · Journal of Virology
  60. Toward Understanding Molecular Bases for Biological Diversification of Human Coronaviruses: Present Status and Future Perspectives
    T. Koma, Shun Adachi, Naoya Doi, A. Adachi, Masako Nomaguchi · 2020 · Frontiers in Microbiology
  61. Establishment of a human organoid-based evaluation system for assessing interspecies infection risk of animal-borne coronaviruses
    Qian-Chun Gong, Ren-Di Jiang, Lina Ji, Haofeng Lin, Meiqin Liu, Xiaofang Tang, Yong Yang, Wei Han, Jing Chen, Zishuo Guo et al. · 2024 · Emerging Microbes & Infections
  62. An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo
    Nian Zhou, Su Tang, Xuelin Bian, Maloy Kumar Parai, Inna V. Krieger, Armando Flores, Pradeep K. Jaiswal, Radha Bam, Jeremy L. Wood, Zhe Shi et al. · 2024 · Cell Reports
  63. Host microRNAs regulate expression of hepatitis B virus genes during transmission from patients’ sperm to embryo
    Jihua Huang, Tingting Han, Ling‐Xiao Li, Ting Qu, Xinyue Zhang, Liao Xue, Ying Zhong · 2020 · Reproductive Toxicology
  64. SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeys
    Kevin O. Saunders, Esther Lee, Robert Parks, David R. Martinez, Dapeng Li, Haiyan Chen, Robert J. Edwards, S. Gobeil, Maggie Barr, Katayoun Mansouri et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  65. Seroprevalence of Five Zoonotic Pathogens in Wild Ruminants in Xinjiang, Northwest China
    Jianyong Wu, Jianjun Li, Deng-Feng Wang, Yurong Wei, Xiaoxiao Meng, Gunuer Tuerxun, Hongduzi Bolati, Kangkang Liu, Masha Muhan, Ayiqiaolifan Shahan et al. · 2020 · Vector-Borne and Zoonotic Diseases
  66. Broad cross neutralizing antibodies against sarbecoviruses generated by SARS-CoV-2 infection and vaccination in humans
    Yabin Hu, Qian Wu, Fangfang Chang, H. J. Yang, Xiaoyue Zhang, Qijie Wang, Jun Chen, Shishan Teng, Yongchen Liu, Xingyu Zheng et al. · 2024 · npj Vaccines
  67. The zoonotic potential of bat-borne coronaviruses
    Ny Anjara Fifi Ravelomanantsoa, Sarah E. Guth, Angelo F. Andrianiaina, Santino Andry, Anecia Gentles, Hafaliana Christian Ranaivoson, Cara E. Brook · 2020 · Emerging Topics in Life Sciences
  68. Intravenous delivery of GS-441524 is efficacious in the African green monkey model of SARS-CoV-2 infection
    Jared Pitts, Darius M. Babusis, Meghan S. Vermillion, Raju Subramanian, Kim Barrett, Diane S. Lye, Bin Ma, Xiaofeng Zhao, Nicholas C. Riola, Xuping Xie et al. · 2022 · Antiviral Research
  69. Bat-Borne Coronaviruses in Jordan and Saudi Arabia: A Threat to Public Health?
    Laith Naser AL-Eitan, Amneh H. Tarkhan, Mansour A. Alghamdi, Denise A. Marston, Guanghui Wu, Lorraine Marie McElhinney, Ian Hay Brown, Anthony R. Fooks · 2020 · Viruses
  70. Advances in use of mouse models to study the renin-angiotensin system
    Jacqueline M. Emathinger, Jonathan W. Nelson, Susan B. Gurley · 2021 · Molecular and Cellular Endocrinology
  71. Gain-of-function research
    Klaus P. Saalbach · 2022 · Advances in applied microbiology
  72. Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motif
    Blake Marie Hauser, Maya Sangesland, Evan Christopher Lam, Kerri St. Denis, Jared E. Feldman, Ashraf Siddig Yousif, Timothy M. Caradonna, Ty Kannegieter, Alejandro Benjamin Balazs, Daniel Lingwood et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Origin of SARS-CoV-2
    Bülent Çakal · 2020 · Turkiye Klinikleri Journal of Medical Ethics-Law and History
  74. IgG Fc-Binding Peptide-Conjugated Pan-CoV Fusion Inhibitor Exhibits Extended In Vivo Half-Life and Synergistic Antiviral Effect When Combined with Neutralizing Antibodies
    Xiaojie Su, Ziqi Huang, Wei Xu, Qian Wang, Lixiao Xing, Lu Lu, Shibo Jiang, Shuai Xia · 2023 · Biomolecules
  75. Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses
    Megi Rexhepaj, Daniel E. Asarnow, Lisa Perruzza, Young‐Jun Park, Barbara Guarino, Mathew Mccallum, Katja Culap, Christian Saliba, Giada Leoni, Alessio Balmelli et al. · 2024 · Immunity
  76. Distinct pathways for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses
    2024
  77. SARS-CoV-2 Kökeni
    Bahadır Feyzioğlu · 2020 · JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH
  78. Animal models for studying coronavirus infections and developing antiviral agents and vaccines
    Q. Lin, Chunni Lu, Yuqi Hong, Run-Feng Li, Jin-Ding Chen, Weisan Chen, Jian-Xin Chen · 2022 · Antiviral Research
  79. Severe acute respiratory syndrome (SARS) related coronavirus in bats
    Rong Geng, Peng Zhou · 2021 · Animal Diseases
  80. Structural Requirements and Plasticity of Receptor-Binding Domain in Human Coronavirus Spike
    Yajuan Li, Peiyi Zheng, Tingting Liu, Cuixiao Shi, Bo Wang, Yuanhong Xu, Tengchuan Jin · 2022 · Frontiers in Molecular Biosciences
  81. Computational investigation reveals that the mutant strains of SARS-CoV2 have differential structural and binding properties
    Rakesh Kumar, Rahul Kumar, Harsh Goel, Pranay Tanwar · 2021 · Computer Methods and Programs in Biomedicine
  82. The Upper Respiratory Tract Microbiome Network Impacted by SARS-CoV-2
    Wendy Li, Zhanshan Sam Ma · 2022 · Microbial Ecology
  83. Strategy To Assess Zoonotic Potential Reveals Low Risk Posed by SARS-Related Coronaviruses from Bat and Pangolin
    Yong Yang, Xu-Rui Shen, Yulan Zhang, Ren-Di Jiang, Xi Wang, Zhenqiong Guan, Qian Li, Yulin Yao, Qian-Chun Gong, Rong Geng et al. · 2023 · mBio
  84. Host genes regulate transcription of sperm-introduced hepatitis B virus genes in embryo
    Ying Zhong, Dongling Liu, Mohamed Morsi M. Ahmed, Peng-Hao Li, Xiaoling Zhou, Qing‐Dong Xie, Xiaoqing Xu, Tingting Han, Zhiwei Hou, Chen-Yao Zhong et al. · 2017 · Reproductive Toxicology
  85. Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice
    Meiqin Liu, Ren-Di Jiang, Jing Hui Guo, Ying Chen, Dongsheng Yang, Xi Wang, Haofeng Lin, Ang Li, Bei Li, Ben Hu et al. · 2022 · Journal of Virology
  86. Translating animal models of SARS-CoV-2 infection to vascular, neurological and gastrointestinal manifestations of COVID-19
    James Chung, Julia Pierce, Craig L. Franklin, Rachel M. Olson, Alan Morrison, James M Amos-Landgraf · 2025 · Disease Models & Mechanisms
  87. Update on animal models for COVID‐19 research
    Simon J. Cleary, Mélia Magnen, Mark R. Looney, Clive Peter Page · 2020 · British Journal of Pharmacology
  88. Epidemiology of coronaviruses, genetics, vaccines, and scenario of current pandemic of coronavirus diseases 2019 (COVID-19): a fuzzy set approach
    Fazal Mehmood Khan, Tauseef Ahmad, Muhammad Gulistan, Wathek Chammam, Muhammad Khan, Hui Jin · 2021 · Human Vaccines & Immunotherapeutics
  89. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19
    S. Tiwari, G. Goel, Ajay Kumar · 2022 · International Reviews of Immunology
  90. Genetic loci regulate Sarbecovirus pathogenesis: A comparison across mice and humans
    Alexandra Schäfer, Lisa E. Gralinski, Sarah R. Leist, Brea K. Hampton, Michael A. Mooney, Kara Jensen, Rachel L. Graham, Sudhakar Agnihothram, Sophia Jeng, Steven R. Chamberlin et al. · 2024 · Virus Research
  91. Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update
    Lu Sang, Xiaoqin Guo, Jie Shi, Shike Hou, Haojun Fan, Qi Lv · 2021 · Stem Cells International
  92. Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions
    Andrea R. Shiakolas, Kevin J. Kramer, D. Wrapp, S. Richardson, A. Schäfer, Steven J. Wall, Nian-Shuang Wang, Katarzyna Janowska, Kelsey A. Pilewski, R. Venkat et al. · 2020 · bioRxiv
  93. Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif
    Blake Marie Hauser, Maya Sangesland, Kerri St. Denis, Ian W. Windsor, Jared E. Feldman, Evan Christopher Lam, Ty Kannegieter, Alejandro Benjamin Balazs, Daniel Lingwood, Aaron G. Schmidt · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses
    Ruiz, Felicitas, Foreman, William B., Lilly, Michelle, Baharani, Viren A., Depierreux, Delphine M., Chohan, Vrasha, Taylor, Ashley L., Guenthoer, Jamie, Ralph, Duncan, Matsen IV, Frederick A. et al. · 2024 · PLOS Pathogens
  95. Development and characterization of a fully humanized ACE2 mouse model
    Chunyu Ge, Amr R. Salem, Amany Elsharkawy, Janhavi Prasad Natekar, Anchala Guglani, Jaser Doja, Osarume Ogala, Gavin Wang, Susan H. Griffin, Orazio J. Slivano et al. · 2025 · BMC Biology
  96. Bat sarbecovirus WIV1-CoV bears an adaptive mutation that alters spike dynamics and enhances ACE2 binding
    Alexandra L. Tse, Gorka Lasso, Jacob L. Berrigan, Jason S. McLellan, Kartik Chandran, Emily Happy Miller · 2025 · PLoS Pathogens
  97. Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design
    Blake Marie Hauser, Jared E. Feldman, Maya Sangesland, Larance Ronsard, Kerri St. Denis, Maegan L. Sheehan, Yi Cao, Julie Boucau, Ian W. Windsor, Agnes H. Cheng et al. · 2022 · Cell Reports Medicine
  98. Deamidation drives molecular aging of the SARS-CoV-2 spike protein receptor-binding motif
    Ramiro Lorenzo, Lucas A. Defelipe, Lucio Aliperti, Stephan Niebling, Tânia F. Custódio, Christian Löw, Jennifer Schwarz, Kim Remans, Patricio O. Craig, Lisandro Horacio Otero et al. · 2021 · Journal of Biological Chemistry
  99. Neurotropism and blood-brain barrier involvement in COVID-19
    Takashi Fujimoto, Michelle A. Erickson, William A. Banks · 2022 · Frontiers in Drug Delivery
  100. Drug screening and development from the affinity of S protein of new coronavirus with ACE2
    Yuepeng Jiang, Xiaoxuan Zhao, Huiqing Lv, Chengping Wen · 2020 · European Journal of Clinical Microbiology & Infectious Diseases